Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Carboplatin Respiratory System Disorder	Nanfang Hospital, Southern Medical University	P3	BBB (72)
Carboplatin Respiratory Tract Neoplasm	Fundación GECP	P3	BBB (72)
Carboplatin Neoplasm Of Thorax	Fundación GECP	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Adenosquamous Lung Carcinoma	Barbara Ann Karmanos Cancer Institute	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Esophageal Cancer	Shenyang Sunshine Pharmaceutical Co., LTD.	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Fallopian Tube Endometrioid Adenocarcinoma	Ohio State University Comprehensive Cancer Center	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Fallopian Tube Mucinous Adenocarcinoma	Ohio State University Comprehensive Cancer Center	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Fallopian Tube Serous Adenocarcinoma	Ohio State University Comprehensive Cancer Center	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Fallopian Tube Carcinoma	Mayo Clinic	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Lung Neoplasm	Nanfang Hospital, Southern Medical University	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Metastatic Prostate Carcinoma	The First Affiliated Hospital of Xiamen University	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Urethra Transitional Cell Carcinoma	Nagoya University	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Ovarian Endometrioid Adenocarcinoma	Genelux Corporation	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Ovarian Mucinous Adenocarcinoma	Ohio State University Comprehensive Cancer Center	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Ovarian Serous Adenocarcinoma	Genelux Corporation	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Primary Peritoneal Serous Adenocarcinoma	Ohio State University Comprehensive Cancer Center	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Skin Cancer	Toray Industries, Inc	P3	BBB (72)
Cis-Diamminedichloroplatinum Ii Uterine Cervix Neoplasm	Merck Sharp & Dohme LLC	P3	BBB (72)
Cytarabine Cancer	Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.	P3	BBB (72)
Cytarabine T-Cell Childhood Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	BBB (72)
Cytarabine T-Lymphoblastic Lymphoma	Children's Oncology Group	P3	BBB (72)
Duvelisib Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Ruijin Hospital	P3	BBB (72)
Encorafenib Melanoma	The Christie NHS Foundation Trust	P3	BBB (72)
Eribulin HER2 Positive Breast Carcinoma	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	P3	BBB (72)
Eribulin Triple-Negative Breast Carcinoma	Hu Hai	P3	BBB (72)

Showing 2626 to 2650 of 42,289 assets

PreviousPage 106 of 1692Next